Trials / Unknown
UnknownNCT00517322
Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Università degli Studi dell'Insubria · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Aim of the study is to compare in hypertensive patients the effect of one year therapy with ACE-inhibitor (RAMIPRIL) or angiotensin II receptor blocker (IRBESARTAN) on left atrial remodelling and diastolic function.
Conditions
- Left Atrial Volume
- Hypertensive Heart Disease
- Antihypertensive Drugs
- Diastolic Function
- Renin Angiotensin System
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ramipril | ramipril 2.5- 5 mg once daily |
| DRUG | irbesartan | irbesartan 150-300 mg once daily |
Timeline
- Start date
- 2007-08-01
- Completion
- 2010-08-01
- First posted
- 2007-08-16
- Last updated
- 2007-08-16
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00517322. Inclusion in this directory is not an endorsement.